BioAmber Inc. announced unaudited consolidated earnings results for the second quarter ended June 30, 2015. For the period, revenue was $342,000 against $415,000 a year ago. Operating loss was $10,894,000 against $10,378,000 a year ago. Net loss was $14,826,000 against $14,145,000 a year ago. Net loss attributable to the company's shareholders was $14,026,000 against $13,992,000 a year ago. Net loss per share attributable to the company's basic shareholders was $0.58 against $0.75 a year ago. Net cash used in operating activities was $15,571,000 against $7,951,000 a year ago. Acquisition of property and equipment was $52,433,000 against $32,728, 000 a year ago. Adjusted net loss attributable to the company's shareholders was $9,529,000 against $7,465,000 a year ago. Adjusted net loss per share attributable the company's basic shareholders was $0.39 against $0.40 a year ago.

For the quarter, impairment loss was $1,141,000.